Eckhardt, CL, van Velzen, AS, Peters, M, Astermark, J, Brons, PP, Castaman, G, Cnossen, MH, Dors, N, Escuriola-Ettingshausen, C, Hamulyak, K, Hart, DP, Hay, CRM, Haya, S, van Heerde, WL, Hermans, C, Holmstrom, M, Jimenez-Yuste, V, Keenan, RD, Klamroth, R, Laros-van Gorkom, BAP, Leebeek, FWG, Liesner, R
, Mäkipernaa, AM-T, Male, C, Mauser-Bunschoten, E, Mazzucconi, MG, Mcrae, S, Meijer, K, Mitchell, M, Morfini, M, Nijziel, M, Oldenburg, J, Peerlinck, K, Petrini, P, Platokouki, H, Reitter-Pfoertner, SE, Santagostino, E, Schinco, P, Smiers, FJ, Siegmund, B, Tagliaferri, A, Yee, TT, Kamphuisen, PW, van der Bom, JG, Fijnvandraat, K & INSIGHT Study Grp 2013, '
Factor VIII gene (F8) mutation and risk of inhibitor development in nonsevere hemophilia A',
Blood, vol. 122, nr. 11, s. 1954-1962.
https://doi.org/10.1182/blood-2013-02-483263